Enzychem
183490.KQEnzychem Lifesciences Corporation Price (183490.KQ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
78,812,124
(7.2026)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Enzychem Lifesciences CorporationCurrency: KRW
| YEAR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
21.84B
+0% |
26.13B
+20% |
31.03B
+19% |
31.47B
+1% |
25.82B
-18% |
22.98B
-11% |
26.64B
+16% |
76.04B
+185% |
77.38B
+2% |
||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 18.85B | 22.58B | 27.18B | 29.35B | 24.49B | 23.35B | 25.02B | 71.69B | 73.07B | ||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
2.98B
+0% |
3.55B
+19% |
3.85B
+8% |
2.12B
-45% |
1.32B
-38% |
-376,789,465.00
-128% |
1.62B
-530% |
4.35B
+169% |
4.31B
-1% |
||||||||||
| Gross Profit Ratio | (0.14%) | (0.14%) | (0.12%) | (0.07%) | (0.05%) | (-0.02%) | (0.06%) | (0.06%) | (0.06%) | ||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 5.15B | 4.20B | 10.16B | 11.44B | 12.87B | 9.50B | 6.70B | 5.43B | 4.42B | ||||||||||
| General and Administrative | 0.00 | 45.73M | 4.45B | 4.88B | 1.41B | 2.19B | 1.76B | 2.09B | 1.94B | ||||||||||
| Selling, General & Admin... | 4.06B | 4.73B | 8.65B | 7.08B | 7.57B | 10.88B | 9.72B | 12.59B | 6.36B | ||||||||||
| Selling & Marketing Exp... | 0.00 | 1.90B | 4.20B | 2.20B | 2.04B | 2.89B | 2.76B | 4.11B | 4.42B | ||||||||||
| Depreciation and Amortiz... | 1.34B | 1.58B | 1.53B | 1.95B | 2.04B | 2.11B | 2.39B | 3.51B | 3.46B | ||||||||||
| Other Expenses | 0.00 | -15,708,210.00 | -6,419,630.00 | -374,620.00 | 1.28B | 312.95M | 14.30M | 0.00 | 6.73B | ||||||||||
| Total Operating Expenses | 9.21B | 8.95B | 18.82B | 18.53B | 19.15B | 20.38B | 16.42B | 18.70B | 17.50B | ||||||||||
| Cost and Exponses | 28.06B | 31.53B | 46.00B | 47.87B | 43.65B | 43.73B | 41.44B | 90.40B | 90.57B | ||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
-6,226,600,970.00
+0% |
-5,396,138,010.00
-13% |
-14,970,330,750.00
+177% |
-16,402,555,380.00
+10% |
-17,829,539,360.00
+9% |
-20,753,516,320.00
+16% |
-14,802,525,780.00
-29% |
-14,356,144,690.00
-3% |
-13,193,969,760.00
-8% |
||||||||||
| Operating Income Ratio | (-0.29%) | (-0.21%) | (-0.48%) | (-0.52%) | (-0.69%) | (-0.90%) | (-0.56%) | (-0.19%) | (-0.17%) | ||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 109.13M | 127.73M | 260.26M | 691.24M | 552.02M | 963.71M | 3.98B | 5.49B | 5.21B | ||||||||||
| Interest Expenses | 221.87M | 184.89M | 110.49M | 158.27M | 1.43B | 9.51B | 10.03B | 620.09M | 238.70M | ||||||||||
| Total Other Income/Exp... | -68,632,290.00 | -236,016,056.00 | 48.25M | -272,975,219.00 | -124,555,070.00 | -8,750,902,040.00 | -10,778,855,850.00 | 4.48B | -8,890,516,750.00 | ||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | -4,787,913,381.00 | -3,868,663,939.00 | -12,637,421,778.00 | -14,455,530,470.00 | -15,715,794,369.00 | -17,874,169,555.00 | -13,156,023,050.00 | -5,773,704,342.00 | -18,387,289,660.00 | ||||||||||
| EBITDA ratio | (-0.22%) | (-0.15%) | (-0.43%) | (-0.46%) | (-0.61%) | (-0.81%) | (-0.47%) | (-0.08%) | (-0.24%) | ||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | -6,295,233,270.00 | -5,632,154,066.00 | -14,280,967,611.00 | -17,380,230,349.00 | -19,181,335,127.00 | -29,493,587,411.00 | -25,575,442,283.00 | -9,878,951,910.00 | -22,084,486,510.00 | ||||||||||
| Income Before Tax Ratio | (-0.29%) | (-0.22%) | (-0.46%) | (-0.55%) | (-0.74%) | (-1.28%) | (-0.96%) | (-0.13%) | (-0.29%) | ||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 36.39M | 34.27M | 139.26M | 203.55M | -1,725,070,031.00 | -1,639,585,514.00 | -488,271,922.00 | -476,299,606.00 | 3.12M | ||||||||||
| Net Income | |||||||||||||||||||
| Net Income | -6,331,627,332.00
+0% |
-5,666,427,603.00
-11% |
-14,420,230,902.00
+154% |
-16,879,076,539.00
+17% |
-17,506,927,997.00
+4% |
-27,864,832,842.00
+59% |
-25,093,109,710.00
-10% |
-9,326,411,514.00
-63% |
-22,106,613,850.00
+137% |
||||||||||
| Net Income Ratio | (-0.29%) | (-0.22%) | (-0.46%) | (-0.54%) | (-0.68%) | (-1.21%) | (-0.94%) | (-0.12%) | (-0.29%) | ||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | -127.66 | -109.39 | -251.00 | -284.31 | -284.83 | -558.47 | -318.36 | -109.81 | -280.50 | ||||||||||
| Diluted EPS | -127.66 | -109.39 | -251.00 | -284.31 | -284.83 | -558.47 | -318.36 | -109.81 | -280.50 | ||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 49.60M | 51.80M | 57.45M | 59.37M | 61.46M | 49.89M | 78.82M | 84.93M | 78.81M | ||||||||||
| Diluted Share Outstanding | 49.60M | 51.80M | 57.45M | 59.37M | 61.46M | 49.89M | 78.82M | 84.93M | 78.81M | ||||||||||